早期毒性試験の市場規模 - 手法・エンドユーザー別 - 地域別展望・競合戦略・セグメント予測 (～2033年)

世界の早期毒性試験の市場規模は、2033年にかけて7.41％のCAGRで推移し、25億8,000万米ドルの規模に成長すると予測されています。

新規化合物の早期毒性評価は、医薬品の開発や既存分子の治療可能性を高めるために用いられます。前臨床段階では、物質の生物種、器官、用量特異的な有害作用を調べるために、多くの生物系で実施されます。動物を用いたin vivo、実験室での試験によるin vitro、コンピューター上でのin silicoなど、さまざまな方法で実施されます。また、化学物質への偶発的な暴露の調査にも用いられます。

規制当局はCOVID-19の治療薬とワクチンの緊急の必要性を認識し、審査プロセスを加速し、規制の柔軟性を拡大しました。これにより、承認までの期間が短縮され、リアルタイムのデータ共有と協力がより重視されるようになり、早期毒性試験の規制状況が変化した可能性があります。この流行は、学界、産業界、政府間の協力と連携を促し、COVID-19の研究の取り組みを強化させました。

当レポートでは、世界の早期毒性試験の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 促進要因・抑制要因・機会・課題の分析
• COVID-19の市場への影響

第5章 市場変数と見通し

• SWOT分析
• PESTEL分析
• ポーターのファイブフォース分析
• ヒートマップ分析

第6章 競合情勢

• 製造拠点の分布・販売エリア・製品タイプ
• M&A・提携・製品発売・協力

第7章 世界の早期毒性試験市場：手法別

• 世界市場の規模・シェア・予測
• In vivo
• In silico
• In vitro

第8章 世界の早期毒性試験市場：エンドユーザー別

• 世界市場の規模・シェア・予測
• 製薬
• 化粧品
• 化学
• 食品
• その他

第9章 世界の早期毒性試験市場の予測

• 市場規模・市場シェア

第10章 世界の早期毒性試験市場：地域別

• 市場規模・市場シェアの推移・予測
• アジア太平洋
• 欧州
• 中東・アフリカ
• 北米
• ラテンアメリカ

第11章 企業プロファイル

• Agilent Technologies
• Accelrys
• BD bioscience
• Bio-rad
• Bioanalytical Systems
• Charles River Laboratories
• Evotec AG
• Enzo Biochem Inc
• Eurofins Scientific
• その他

第12章 総論

第13章 略語一覧

第14章 参考リンク

Early Toxicity Testing Market Introduction and Overview

According to SPER market research, 'Early Toxicity Testing Market Size- By Technique, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Early Toxicity Testing Market is predicted to reach USD 2.58 billion by 2033 with a CAGR of 7.41%.

Early toxicity assessment of novel compounds is used to develop medications and increase the therapeutic potential of existing molecules. It is carried out in pre-clinical phases on numerous biological systems to explore the species, organs, and dose-specific harmful effects of a substance. It can be carried out in a variety of ways, including in vivo on animals, in vitro in laboratories with tests, and in silico on a computer. It is also used to research accidental exposures to a chemical.

Recognizing the urgent need for COVID-19 therapies and vaccinations, regulatory agencies accelerated review processes and extended regulatory flexibility. This may have altered the regulatory landscape for early toxicity testing, with shorter approval timelines and a stronger emphasis on real-time data sharing and collaboration. The epidemic prompted collaboration and collaborations among academia, industry, and government to boost COVID-19 research efforts.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Technique, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Agilent Technologies, Accelrys, BD bioscience, Bio-rad, Bioanalytical Systems, Charles River Laboratories, Evotec AG Enzo Biochem Inc, Eurofins Scientific

Global Early Toxicity Testing Market Segmentation:

By Technique: Based on the Technique, Global Early Toxicity Testing Market is segmented as; In vivo, In silico, In vitro.

By End User: Based on the End User, Global Early Toxicity Testing Market is segmented as; Pharmaceuticals industry, Cosmetics industry, Chemicals industry, Food industry, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Early Toxicity Testing Market.

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Early Toxicity Testing Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Early Toxicity Testing Market

7. Global Early Toxicity Testing Market, By Technique (USD Million) 2020-2033

7.1. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2020-2026

• 7.2. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2027-2033
• 7.3. In vivo
• 7.4. In silico
• 7.5. In vitro

8. Global Early Toxicity Testing Market, By End User (USD Million) 2020-2033

• 8.1. Global Early Toxicity Testing Market Size, Share and Forecast, By End User, 2020-2026
• 8.2. Global Early Toxicity Testing Market Size,Share and Forecast, By End User, 2027-2033
• 8.3. Pharmaceuticals industry
• 8.4. Cosmetics industry
• 8.5. Chemicals industry
• 8.6. Food industry
• 8.7. Others

9. Global Early Toxicity Testing Market Forecast, 2020-2033 (USD Million)

• 9.1. Global Early Toxicity Testing Market Size and Market Share

10. Global Early Toxicity Testing Market, By Region, 2020-2033 (USD Million)

• 10.1. Global Early Toxicity Testing Market Size and Market Share By Region (2020-2026)
• 10.2. Global Early Toxicity Testing Market Size and Market Share By Region (2027-2033)
• 10.3. Asia-Pacific
  • 10.3.1. Australia
  • 10.3.2. China
  • 10.3.3. India
  • 10.3.4. Japan
  • 10.3.5. South Korea
  • 10.3.6. Rest of Asia-Pacific
• 10.4. Europe
  • 10.4.1. France
  • 10.4.2. Germany
  • 10.4.3. Italy
  • 10.4.4. Spain
  • 10.4.5. United Kingdom
  • 10.4.6. Rest of Europe
• 10.5. Middle East and Africa
  • 10.5.1. Kingdom of Saudi Arabia
  • 10.5.2. United Arab Emirates
  • 10.5.3. Qatar
  • 10.5.4. South Africa
  • 10.5.5. Egypt
  • 10.5.6. Morocco
  • 10.5.7. Nigeria
  • 10.5.8. Rest of Middle East & Africa
• 10.6. North America
  • 10.6.1. Canada
  • 10.6.2. Mexico
  • 10.6.3. United States
• 10.7. Latin America
  • 10.7.1. Argentina
  • 10.7.2. Brazil
  • 10.7.3. Rest of Latin America

11. Company Profile

• 11.1. Agilent Technologies
  • 11.1.1. Company details
  • 11.1.2. Financial outlook
  • 11.1.3. Product summary
  • 11.1.4. Recent developments
• 11.2. Accelrys
  • 11.2.1. Company details
  • 11.2.2. Financial outlook
  • 11.2.3. Product summary
  • 11.2.4. Recent developments
• 11.3. BD bioscience
  • 11.3.1. Company details
  • 11.3.2. Financial outlook
  • 11.3.3. Product summary
  • 11.3.4. Recent developments
• 11.4. Bio-rad
  • 11.4.1. Company details
  • 11.4.2. Financial outlook
  • 11.4.3. Product summary
  • 11.4.4. Recent developments
• 11.5. Bioanalytical Systems
  • 11.5.1. Company details
  • 11.5.2. Financial outlook
  • 11.5.3. Product summary
  • 11.5.4. Recent developments
• 11.6. Charles River Laboratories
  • 11.6.1. Company details
  • 11.6.2. Financial outlook
  • 11.6.3. Product summary
  • 11.6.4. Recent developments
• 11.7. Evotec AG
  • 11.7.1. Company details
  • 11.7.2. Financial outlook
  • 11.7.3. Product summary
  • 11.7.4. Recent developments
• 11.8. Enzo Biochem Inc
  • 11.8.1. Company details
  • 11.8.2. Financial outlook
  • 11.8.3. Product summary
  • 11.8.4. Recent developments
• 11.9. Eurofins Scientific
  • 11.9.1. Company details
  • 11.9.2. Financial outlook
  • 11.9.3. Product summary
  • 11.9.4. Recent developments
• 11.10. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links